NCT03101761View on ClinicalTrials.gov

Characteristics and the Future of the City Chilblains

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

February 28, 2017

Conditions
Chilblains
Trial Locations (1)

75014

Groupe Hospitalier Paris Saint Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT03101761 - Characteristics and the Future of the City Chilblains | Biotech Hunter | Biotech Hunter